Sangamo Therapeutics (SGMO) Insider Trading & Ownership $1.09 -0.01 (-0.91%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Sangamo Therapeutics (NASDAQ:SGMO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.80%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$25,032.96Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$5.13 M Get SGMO Insider Trade Alerts Want to know when executives and insiders are buying or selling Sangamo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SGMO Insider Buying and Selling by Quarter Sangamo Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/26/2023Biogen Inc.Major ShareholderSell6,000,000$0.50$3,000,000.00 8/29/2022Biogen Inc.Major ShareholderSell400,000$5.33$2,132,000.00 6/3/2022John MarkelsDirectorBuy6,784$3.69$25,032.96 (Data available from 1/1/2013 forward) SGMO Insider Trading Activity - Frequently Asked Questions Who is on Sangamo Therapeutics's Insider Roster? The list of insiders at Sangamo Therapeutics includes Biogen Inc., and John Markels. Learn more on insiders at SGMO. What percentage of Sangamo Therapeutics stock is owned by insiders? 2.80% of Sangamo Therapeutics stock is owned by insiders. Learn more on SGMO's insider holdings. Which Sangamo Therapeutics insiders have been selling company stock? The following insider sold SGMO shares in the last 24 months: Biogen Inc. ($3,000,000.00). How much insider selling is happening at Sangamo Therapeutics? Insiders have sold a total of 6,000,000 Sangamo Therapeutics shares in the last 24 months for a total of $3,000,000.00 sold. Sangamo Therapeutics Key ExecutivesDr. Alexander D. Macrae Ch.B (Age 61)M.B., MRCP, Ph.D., CEO, President & Director Compensation: $722.67kDr. Nathalie Dubois-Stringfellow Ph.D. (Age 62)Senior VP & Chief Development Officer Compensation: $459.9kMs. Amy Pooler Ph.D.Head of ResearchMr. Gregory Davis Ph.D.Head of TechnologyMs. Aron FeingoldHead of Corporate Communications & Investor Relations OfficerMr. Scott B. Willoughby (Age 49)Senior VP, General Counsel & Corporate Secretary Phillip RamseyHead of Technical OperationsMs. Stephanie J. Seiler CLPHead of Business Development & Alliance ManagementMr. David OjalaScientist II - Discovery & Translational ResearchLouise WilkieVice President of Investor Relations & Corporate Communications More Insider Trading Tools from MarketBeat Related Companies IRWD Insider Trades EBS Insider Trades CDXS Insider Trades RIGL Insider Trades XOMA Insider Trades VNDA Insider Trades VSTM Insider Trades LXRX Insider Trades ACHV Insider Trades RGLS Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:SGMO) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sangamo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sangamo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
